Dr. Atluri is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
676 N Saint Clair St
Ste 850
Chicago, IL 60611Phone+1 312-695-6180Fax+1 312-695-6189
Summary
- Himachandana Atluri, MD, is an Internal Medicine specialist with subspecialties in Hematology and Oncology, currently based in Chicago, IL. She completed her medical education at the University of Missouri Kansas City School of Medicine in 2017, followed by a residency and chief residency in Internal Medicine at Washington University/B-JH/SLCH Consortium, and a fellowship in Hematology and Medical Oncology at the University of Texas Health Science Center at Houston/M D Anderson Cancer Center. As of 2024, she serves as an Assistant Professor at Northwestern Memorial Hospital and holds a position as a Clinical Fellow at UT MD Anderson Cancer Center. Her research work has been published in various journals and includes studies on hemolytic transfusion reactions and germline predisposition syndromes in hematologic malignancies. Dr. Atluri is also involved in clinical trials, including research on Baricitinib for graft-versus-host disease prophylaxis.
Education & Training
- University of Texas Health Science Center at Houston/M D Anderson Cancer CenterFellowship, Hematology and Medical Oncology, 2021 - 2024
- Washington University/B-JH/SLCH ConsortiumChief Residency, Internal Medicine, 2020 - 2021
- Washington University/B-JH/SLCH ConsortiumResidency, Internal Medicine, 2017 - 2020
- University of Missouri Kansas City School of MedicineClass of 2017
Certifications & Licensure
- TX State Medical License 2021 - 2027
- IL State Medical License 2020 - 2026
- MO State Medical License 2017 - 2026
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Baricitinib for the Prophylaxis of Graft-Versus-Host Disease After Peripheral Blood Hematopoietic Cell Transplantation Start of enrollment: 2020 Apr 07
Publications & Presentations
PubMed
- Management of hemolytic transfusion reactions in a patient with chronic myelomonocytic leukemia and rare antibodies: A case report.Grace S Park, Himachandana Atluri, Courtney D DiNardo, Bryan Guillroy, Jean Horak
Leukemia Research Reports. 2025-01-01 - 4 citationsApproach Toward Germline Predisposition Syndromes in Patients with Hematologic Malignancies.Himachandana Atluri, Yoheved S Gerstein, Courtney D DiNardo
Current Hematologic Malignancy Reports. 2022-12-01 - 16 citationsA randomized feasibility study evaluating temozolomide circadian medicine in patients with glioma.Anna R Damato, Ruth G N Katumba, Jingqin Luo, Himachandana Atluri, Grayson R Talcott
Neuro-Oncology Practice. 2022-05-01
Press Mentions
- Can Leukemia Be Treated with a Pill?August 8th, 2024
Professional Memberships
- Member
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: